Eli Lilly develops medicines across diabetes, obesity, oncology, and neuroscience, including its market-defining incretin therapies. Its Lilly Research Laboratories maintain extensive academic alliances and AI partnerships to expand its pipeline.
R&D SPEND
$9.0B
INDUSTRY
Biopharma
460
ACADEMIC COLLABORATIONS
6100
PATENTS
TRY IT
Researchers connected to Eli Lilly
Install the CLI and run your first search in under a minute. No account required to explore.
npx sci-buy@latest COPIED